Filing Details

Accession Number:
0000905148-24-001095
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-03 21:54:32
Reporting Period:
2024-04-01
Accepted Time:
2024-04-03 21:54:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1704292 Zai Lab Ltd ZLAB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1835780 Iii Titus Frazor Edmondson C/O Zai Lab Limited
314 Main Street, 4Th Floor, Suite 100
Cambridge MA 02142
Chief Legal Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Acquisiton 2024-04-01 2,671 $16.72 22,676 No 4 M Direct
American Depositary Shares Acquisiton 2024-04-01 830 $16.72 23,506 No 4 M Direct
American Depositary Shares Disposition 2024-04-02 675 $16.15 22,831 No 4 S Direct
American Depositary Shares Disposition 2024-04-02 210 $16.15 22,621 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
American Depositary Shares Stock Options (Right to Buy) Acquisiton 2024-04-01 84,663 $0.00 84,663 $16.72
American Depositary Shares Restricted Share Units Acquisiton 2024-04-01 55,031 $0.00 55,031 $0.00
American Depositary Shares Restricted Share Units Disposition 2024-04-01 2,671 $0.00 2,671 $0.00
American Depositary Shares Restricted Share Units Disposition 2024-04-01 830 $0.00 830 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
84,663 2034-04-01 No 4 A Direct
55,031 No 4 A Direct
8,013 No 4 M Direct
1,660 No 4 M Direct
Footnotes
  1. Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
  2. ADSs acquired on vesting of Restricted Share Units.
  3. These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units.
  4. Each Stock Option is exercisable for one ADS, which represents ten Ordinary Shares of the issuer.
  5. The option vests in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service.
  6. Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer.
  7. The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting.
  8. The RSUs vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
  9. The RSUs vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.